Intuits Latest Earnings Test Morgan Stanleys Stock Forecast Foreign Investors Offload Over Rs 30000 Crore in Indian Equities in May as 2026 Outflows Reach Rs 222 Lakh Crore China Calls for APEC Cooperation as Commerce Minister Skips Opening Over Urgent Official Business Pinterest Inc Analyst Report Suggests Potential Growth Amid Digital Ad Shifts Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Mine Lithuania Data Breach Compromises 600000 National Records Including Potential Spy Identities ASP Isotopes Q4 2025 Earnings Widerthanexpected loss fails to dampen investor sentiment SI Q1 2026 Earnings NarrowerThanExpected Loss Amid Operational Progress KLAR Q1 2026 Earnings Net Loss Narrows Sharply Beating Estimates by Wide Margin DLTH Q1 2026 Earnings EPS Surges Past Estimates Driving Shares Higher PDEX Q1 2026 Earnings EPS Surges 8975 Above Estimates Amid Stock Decline COYA Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Rises on Efficiency Gains Cohen Steers Infrastructure Fund UTF Edges Higher as Infrastructure Demand Remains Steady Newbury Street II Acquisition Corp Warrant NTWOW Holds Steady at 018 Amid Tight Trading Range Draganfly DPRO Shares Edge Higher Support Tested as Drone Maker Eyes Resistance Childrens Place PLCE Rallies 35 as Oversold Bounce Challenges Resistance Zone Foremost Clean Energy Warrants Surge FMSTW Climbs Nearly 10 as Momentum Builds USIran Standoff Deepens After Trump Rejects Counteroffer Raising Risks for Global Energy Markets Atea Pharmaceuticals Q1 2026 Earnings Narrower Loss Beats Expectations Stock Edges Higher Pattern Group PTRN Surges 412 as Bulls Target Key Resistance GigCapital9 Corp Rights GIXXR Hold Steady at 032 as Support and Resistance Levels Tighten Psyence Biomedical Warrants PBMWW Edge Higher Support and Resistance Converge at 003 Anika Therapeutics Edges Higher as Stock Tests Key Resistance Zone Polaryx Therapeutics PLYX Slips 863 as Biotech Volatility Resurfaces Key Support Levels in Focus enGene Holdings Inc ENGN Gains 349 as Stock Approaches Key Resistance Lexicon Pharmaceuticals LXRX Slides 314 as Shares Test NearTerm Support Levels Enliven Therapeutics ELVN Faces Pressure as Shares Dip 168 Key Support Levels in Focus